The Traderszone Network

Published in TZ Latest News 1 October, 2014 by The TZ Newswire Staff

After Hours: Esperion shares rally on cholesterol drug study

Shares of Esperion Therapeutics rally after the drug developer said its treatment significantly lowered bad cholesterol in patients enrolled in a clinical trial.
read more